Eli Lilly and Company Profile Avatar - Palmy Investing

Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, H…

Drug Manufacturers - General
US, Indianapolis [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2023 4 $6,000,000 LD-2 : 01/22/24
2023 4 $5,000,000 LD-2 : 01/19/24
2023 4 $6,000,000 LD-2 : 01/18/24
2023 4 $8,000,000 LD-2 : 01/13/24
2023 4 $8,000,000 LD-2 : 01/13/24

Get PRO Today

With PRO you will unlock 15 more lobbying disclosures for Eli Lilly and Company

End of LLY's Analysis
CIK: 59478 CUSIP: 532457108 ISIN: US5324571083 LEI: - UEI: -
Secondary Listings